Patrick Lucy, Lykan Bioscience CEO

Two CD­MOs come to­geth­er as they look to ex­pand their reach in cell ther­a­py man­u­fac­tur­ing

As the cell ther­a­py field has ma­tured, the man­u­fac­tur­ing of such ther­a­pies be­comes a greater fo­cus for com­pa­nies small and large. Amid this …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.